PEX13 (NM_002618) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC209140L1V

  • LentiORF®

Lenti ORF particles, PEX13 (Myc-DDK tagged) - Human peroxisomal biogenesis factor 13 (PEX13), 200ul, >10^7 TU/mL

Biosafety Sheet

USD 820.00

3 Weeks*

Size
    • 200 ul

Product Images

Other products for "PEX13"

Specifications

Product Data
Type Human Tagged ORF Clone Lentiviral Particle
Tag Myc-DDK
Symbol PEX13
Synonyms NALD; PBD11A; PBD11B; ZWS
Vector pLenti-C-Myc-DDK
ACCN NM_002618
ORF Size 1209 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC209140).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_002618.2, NP_002609.1
RefSeq Size 4524 bp
RefSeq ORF 1212 bp
Locus ID 5194
Cytogenetics 2p15
Domains SH3, Peroxin-13_N
Protein Families Druggable Genome
MW 44.1 kDa
Gene Summary 'This gene encodes a peroxisomal membrane protein that binds the type 1 peroxisomal targeting signal receptor via a SH3 domain located in the cytoplasm. Mutations and deficiencies in peroxisomal protein importing and peroxisome assembly lead to peroxisomal biogenesis disorders, an example of which is Zellweger syndrome. [provided by RefSeq, Oct 2008]'

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.